: The acquisition of assets from bankrupt rival Rite Aid has added roughly 9 million new patients to its pharmacy network. Potential Risks to Consider
: The stock trades at roughly 11x forward earnings , significantly below its historical average of 12-15x. Morningstar estimates a fair value of $97.00 . should i buy cvs stock
Some analysts project a 12-month price target averaging , implying over 20% upside. : The acquisition of assets from bankrupt rival
: CVS offers a 3.4% dividend yield , which is more than double the S&P 500 average. Some analysts project a 12-month price target averaging
CVS Health Corporation (CVS) currently holds a consensus from Wall Street analysts, with 20 out of 24 experts recommending it as a top pick as of late April 2026. Trading near $78.38 , the stock is widely considered an attractive value play due to its low valuation relative to its $400+ billion annual revenue and robust cash flow. Key Investment Highlights
: The company is still managing significant debt from past major acquisitions, such as Aetna. Summary of Analyst Sentiment (April 2026) Percentage Strong Buy Buy Hold/Sell
: While 2026 rates were better than feared, fluctuating Medicare reimbursement and higher medical utilization costs can squeeze insurance margins.